| 9782429 |
Formulation having mobilizing activity |
Roberto Porta, Massimo Iacobelli, Alessandro Massimo Gianni, Carmelo Carlo Stella |
2017-10-10 |
| 8771663 |
Formulation having mobilising activity |
Roberto Porta, Massimo Iacobelli, Massimo Alessandro Gianni, Carmelo Carlo Stella |
2014-07-08 |
| 8551967 |
Formulations with anti-tumour action |
Massimo Iacobelli, Paul Richardson |
2013-10-08 |
| 7838506 |
DNA-based aptamers for human cathepsin G |
Manlio Palumbo, Barbara Gatto, Rodolfo Pescador, Roberto Porta |
2010-11-23 |
| 7662777 |
Use of sulglicotide for the treatment of mucositis |
Massimo Iacobelli |
2010-02-16 |
| 7338777 |
Method for determining the biological activity of defibrotide |
Roberto Porta, Franco Cattaneo |
2008-03-04 |
| 6767554 |
Use of complexes among cationic liposomes and polydeoxyribonucleotides and medicaments |
Roberto Porta, Fabio Trento, Claudio Nastruzzi, Elisabetta Esposito, Enea Menegatti |
2004-07-27 |
| 5948405 |
Fucans with low molecular weight having anticoagulant, antithrombinic and antithromobic activity |
Armando Cedro, Roberto Porta, Franco Cattaneo, Fabio Trento, Ennio Lanzarotti |
1999-09-07 |
| 5731302 |
Stable aqueous suspensions of mesalazine |
Giancarlo Farolfi, Franco Lattuada |
1998-03-24 |
| 5676965 |
Use of polydeoxyribonucleotides in diabetic neuropathies |
Ennio Lanzarotti |
1997-10-14 |
| 5605891 |
Use of polysaccharides in acute peripheral neuropathies |
Giuseppe Prino, Ennio Lanzarotti, Benito Casu |
1997-02-25 |